UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040093
Receipt number R000045715
Scientific Title A multi-institutional prospective observational study of LINAC-based single isocenter stereotactic irradiation for multiple brain metastases
Date of disclosure of the study information 2020/04/07
Last modified on 2020/04/07 16:08:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multi-institutional prospective observational study of LINAC-based single isocenter stereotactic irradiation for multiple brain metastases

Acronym

SISTI study

Scientific Title

A multi-institutional prospective observational study of LINAC-based single isocenter stereotactic irradiation for multiple brain metastases

Scientific Title:Acronym

SISTI study

Region

Japan


Condition

Condition

brain metastases

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and feasibility of LINAC-based single isocenter stereotactic irradiation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Local control rate at 6 months after LINAC-based single isocenter stereotactic irradiation per case

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)20 years old or higher
2)Diagnosed as solid malignant tumors (except small-cell lung cancer and malignant lymphoma)
3)2 or more brain metastases as counted on a gadolinium contrast-enhanced MRI (maximum 10 brain metastases)
4)The longest diameter of each gross tumor volume (GTV) is smaller than 3 cm, and each GTV is smaller than 10 cm3. Total volume of all GTV is smaller than 15 cm3.
5)Performance status 0-2 or 3 (only if caused by the tumor)
6)No leptomeningeal metastases
7)No previous surgery or irradiation to the skull or brain.

Key exclusion criteria

1)With severe coexisting diseases such as collagen disease, heart disease, respiratory disease and liver disease.
2)Psychotic disease
3)Contraindications for MRI examination with gadolinium agent use

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Mizowaki

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Radiation Oncology and Image-applied Therapy

Zip code

606-8507

Address

54, Shogoin Kawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3417

Email

mizo@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Mizowaki

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Radiation Oncology and Image-applied Therapy

Zip code

606-8507

Address

54, Shogoin Kawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3417

Homepage URL


Email

mizo@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

MEXT

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 03 Month 10 Day

Date of IRB

2020 Year 03 Month 10 Day

Anticipated trial start date

2020 Year 04 Month 07 Day

Last follow-up date

2024 Year 03 Month 09 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To evaluate the efficacy and feasibility of LINAC-based single isocenter stereotactic irradiation


Management information

Registered date

2020 Year 04 Month 07 Day

Last modified on

2020 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045715


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name